Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker
- KO Validated
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
5
(2 Reviews)
|
(16 Publications)
Rabbit Recombinant Monoclonal Caveolin-1 antibody. N-terminal. Suitable for ICC/IF, IP, WB, Flow Cyt (Intra), IHC-P and reacts with Human, Mouse samples. Cited in 16 publications.
View Alternative Names
CAV, CAV1, Caveolin-1
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
ab192869 staining Caveolin-1 in wild-type HeLa cells (top panel) and CAV1 knockout HeLa cells (bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab192869 at 1/500 dilution and ab7291 (Mouse monoclonal to alpha Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 µg/ml (shown in green) and a goat secondary antibody to mouse IgG (Alexa Fluor® 594) (ab150120) at 2 µg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Intracellular Intracellular Flow Cytometry overlay histogram showing wild-type HeLa (green line) and CAV1 knockout HeLa cells (ab255371) stained with ab192869 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Triton X-100 for 15 min. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab192869) (1x106 in 100μl at 0.04 μg/ml) for 30 min at 22°C.
The secondary antibody Goat anti-rabbit IgG H&L (Alexa Fluorr® 488, pre-adsorbed) (ab150081) was used at 1/2000 for 30 min at 22°C.
Isotype control antibody was Rabbit IgG (monoclonal) (ab172730) used at the same concentration and conditions as the primary antibody (wild-type HeLa - black line CAV1 knockout HeLa - grey line). Unlabelled sample was also used as a control (this line is not shown for the purpose of simplicity).
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Immunocytochemistry/Immunofluorescence analysis of A-673 cells labelling Caveolin-1 with ab192869 at a dilution of 1/100. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. The cells were co-stained with ab195889, Alexa Fluor® 594-conjugated anti-Tubulin [DM1A] at a dilution of 1/200. Nuclei counterstained with DAPI (blue).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling Caveolin-1 using ab192869 at 1/4000 dilution (0.15 μg/ml). A prediluted HRP Polymer for Rabbit IgG was used as the secondary. Counterstain : Hematoxylin. Negative control also shown.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Immunohistochemical analysis of paraffin-embedded Human squamous cell carcinoma of cervix tissue labeling Caveolin-1 using ab192869 at 1/4000 dilution (0.15 μg/ml). A prediluted HRP Polymer for Rabbit IgG was used as the secondary. Counterstain : Hematoxylin. Negative control also shown.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IP
Supplier Data
Immunoprecipitation - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Immunoprecipitation analysis of A431 cell lysate labeling Caveolin-1 using ab192869 at 1/30 dilution (Lane 1). PBS negative control (Lane 2). Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 was used as the secondary antibody.
All lanes:
Immunoprecipitation - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869)
Predicted band size: 20 kDa
false
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Immunohistochemical analysis of paraffin-embeddedMouse lung tissue labeling Caveolin-1 using ab192869 at 1/4000 dilution (0.15 μg/ml). A prediluted HRP Polymer for Rabbit IgG was used as the secondary. Counterstain : Hematoxylin. Negative control also shown.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Intracellular Flow Cytometry analysis of NIH3T3 cells labeling Caveolin-1 using ab192869 at a 1/120 dilution (Red). A Goat anti rabbit IgG (FITC) at 1/150 dilution was used as secondary antibody. Cells were fixed with 2% paraformaldehyde. Cells without incubation with primary antibody and secondary antibody Blue. Rabbit monoclonal IgG was used as isotype control (Black).
- WB
Lab
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Western blot : Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker ab192869 staining at 1/1000 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 20 kDa in Wild-type HeLa cell lysates with no signal observed at this size in CAV1 knockout HeLa cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween™ 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869) at 1/1000 dilution
Lane 1:
Wild-type HeLa whole cell lysate at 20 µg
Lane 2:
CAV1 knockout HeLa whole cell lysate at 20 µg
Lane 3:
Wild-type U-87 MG ab278079 whole cell lysate at 20 µg
Lane 4:
Western blot - Human CAV1 knockout U-87 MG cell line (ab306811) at 20 µg
Lane 5:
A431 whole cell lysate at 20 µg
Lane 6:
Ramos whole cell lysate at 20 µg
Lane 7:
Raji whole cell lysate at 20 µg
Lane 8:
HepG2 whole cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 20 kDa
false
- WB
Lab
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
This data was developed using the same antibody clone in a different buffer formulation (ab192869).
Lanes 1 - 4 : Merged signal (red and green). Green - ab192869 observed at 21-24 kDa. Red - loading control, ab7291 (Mouse anti-Alpha Tubulin [DM1A] observed at 55kDa.
ab192869 was shown to react with Caveolin-1 in wild-type A-431 cells in western blot. Loss of signal was observed when CAV1 knockout cell line ab269583 (knockout cell lysate ab270706) was used. Wild-type A-431 and CAV1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBS-T (0.1% Tween®) before incubation with ab192869 and ab7291 (Mouse anti-Alpha Tubulin [DM1A] overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869) at 1/1000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
CAV1 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human CAV1 (Caveolin-1) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-cav1-caveolin-1-knockout-a-431-cell-line-ab269583'>ab269583</a>)
Lane 3:
A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 4:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Predicted band size: 20 kDa
Observed band size: 21-24 kDa
false
- WB
Unknown
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Lanes 1 - 4 : Merged signal (red and green). Green - ab192869 observed at 20 kDa. Red - loading control, ab8245 observed at 37 kDa.
ab192869 was shown to react with Caveolin-1 in wild-type HeLa. Loss of signal was observed when knockout cell line ab255371 (knockout cell lysate ab263806) was used. Wild-type and Caveolin-1 knockout samples were subjected to SDS-PAGE. ab192869 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 10000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869) at 1/10000 dilution
Lane 1:
A431 cell lysate at 20 µg
Lane 2:
A549 cell lysate at 20 µg
Lane 2:
Western blot - Human CAV1 (Caveolin-1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cav1-caveolin-1-knockout-hela-cell-line-ab255371'>ab255371</a>)
Lane 3:
Wild-type HeLa cell lysate at 20 µg
Lane 4:
CAV1 knockout HeLa cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 20 kDa
Observed band size: 37 kDa
false
- WB
Lab
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
ab192869 was shown to react with CAV1 in wild-type U-87 MG cells in Western blot with loss of signal observed in CAV1 knockout cell line ab306811. Wild-type U-87 MG and CAV1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab192869 overnight at 4 °C at a 1/10000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869) at 1/10000 dilution
Lane 1:
Wild-type U-87 MG lysate at 20 µg
Lane 2:
CAV1 knock-out U-87 MG lysate at 20 µg
Lane 2:
Western blot - Human CAV1 knockout U-87 MG cell line (ab306811)
Observed band size: 22 kDa
false
- WB
Supplier Data
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
All lanes:
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (ab192869) at 1/10000 dilution
Lane 1:
PC-3 cell lysate at 10 µg
Lane 2:
A549 cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 20 kDa
false
- WB
CiteAb
Western blot - Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker (AB192869)
Caveolin-1 western blot using anti-Caveolin-1 antibody [EPR15554] - N-terminal ab192869. Publication image and figure legend from Streleckiene, G., Inciuraite, R., et al., 2020, Int J Mol Sci, PubMed 32013265.
ab192869 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab192869 please see the product overview.
CAV1 and TSC1 proteins level changes after exogenous up-regulation of miR-451a expression. CAV1 (A) and TSC1 (B) protein expression comparison 48 h and 72 h after transfection in AGS and MKN28 cell cultures transfected with miR-451a and miR-control. Significant CAV1 and TSC1 proteins' level decrease was determined 72 h after transfection in AGS cell culture. Representative pictures of CAV1 and TSC1 proteins signals detected by Western Blot presented at the bottom of a figure (* p < 0.05). Data from three independent experiments.
false
Related conjugates and formulations (4)
-
Anti-Caveolin-1 antibody [EPR15554] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker
-
578 PE
PE Anti-Caveolin-1 antibody [EPR15554] - N-terminal - Caveolae Marker
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Caveolae provide a platform for various signaling pathways and involve caveolin-1 as a major component. Caveolin-1 interacts with multiple signaling molecules such as G-protein coupled receptors and Src family kinases to modulate signal transduction. This protein forms part of a larger caveolar complex contributing to cellular processes including endocytosis and lipid regulation. Its presence as a marker in caveolae highlights its significance in cellular functions.
Pathways
Caveolin-1 influences the insulin signaling and nitric oxide (NO) signaling pathways. In the insulin signaling pathway caveolin-1 interacts with insulin receptors to modulate glucose uptake. It also associates with eNOS (endothelial nitric oxide synthase) in the NO signaling pathway impacting vascular function. These relationships highlight its role in cellular communication and regulatory mechanisms within the human body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (16)
Recent publications for all applications. Explore the full list and refine your search
Chemical & pharmaceutical bulletin 73:896-906 PubMed40993069
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 26: PubMed40429837
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 13: PubMed40002894
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:7077 PubMed39152118
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the European Academy of Dermatology and Venereology : JEADV 37:1920-1927 PubMed37262304
2023
Applications
Unspecified application
Species
Unspecified reactive species
Open life sciences 18:20220587 PubMed37077343
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecules (Basel, Switzerland) 27: PubMed35566232
2022
Applications
Unspecified application
Species
Unspecified reactive species
Translational vision science & technology 11:15 PubMed35138344
2022
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 287:5478-5497 PubMed32279424
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 21: PubMed32013265
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com